Concepedia

Tracey L. Rapp

TL

Statistics

Publications

4

Citations

141

H-Index

4

Active since

1978

Affiliations

Pfizer (United States)(Current)

Tracey L. Rapp is an author at Pfizer (United States) specializing in pharmacology, neuropharmacology, and 5-hydroxytryptamine receptor pharmacology.

Publications per year

1978–2013

4

Publications

4

Disposition of valproic acid in patients with liver disease

Ulrich Klotz, Tracey L. Rapp, W. M�ller · European Journal of Clinical Pharmacology · 1978 · 87 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial

Timothy Nicholas, Sridhar Duvvuri, Claire Leurent et al. · Advances in Alzheimer s Disease · 2013 · 29 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Metabolism of a Serotonin-4 Receptor Partial Agonist 4-{4-[4-Tetrahydrofuran-3-yloxy)-Benzo[d]Isoxazol-3-yloxymethyl]-Piperidin-1-ylmethyl}-Tetrahydropyran-4-ol (TBPT): Identification of an Unusual Pharmacologically Active Cyclized Oxazolidine Metabolite in Human

Aarti Sawant‐Basak, Karen J. Coffman, Gregory S. Walker et al. · Journal of Pharmaceutical Sciences · 2013 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

P3‐361: A randomized, double‐blind, sponsor‐unblinded, placebo‐ and positive‐controlled study to evaluate the effects of single oral administrations of PF‐04995274 on scopolamine‐induced deficits in cognitive function in healthy adults

Claire Leurent, Sridhar Duvvuri, David Raunig et al. · Alzheimer s & Dementia · 2012 · 10 citations

Medicine, Neuroscience, Pharmacology +17

1–4 of 4